Oxana Guerassimenko

Title: Innovator Spotlight: Oxana Guerassimenko

Introduction

Oxana Guerassimenko, an accomplished inventor located in Milly-la-Foret, France, has made significant contributions to the field of biomedical research. With a remarkable portfolio of 13 patents, her work primarily focuses on innovative therapeutic approaches for treating Alzheimer's disease and related disorders.

Latest Patents

Guerassimenko's latest patents showcase her groundbreaking contributions to Alzheimer's research. Her first patent discusses therapeutic approaches for treating Alzheimer's disease through a modulation of angiogenesis. This invention emphasizes compositions and methods that employ combined therapies, aiming to enhance the treatment of this complex disease. Additionally, her second patent highlights therapeutic approaches that target synapse function in relation to Alzheimer's disease. This invention also outlines combined therapies that leverage synapse modulation as a means to combat the disease.

Career Highlights

Throughout her career, Oxana Guerassimenko has been affiliated with prominent organizations such as Pharnext and the Serono Genetics Institute. Her work at these institutions has been pivotal in advancing our understanding of Alzheimer's disease, blending her knowledge in biology with innovative therapeutic methods.

Collaborations

Guerassimenko has collaborated with notable professionals in her field, including Ilya Chumakov and Daniel Cohen. These partnerships have fostered a collaborative environment, facilitating the sharing of ideas and accelerating the development of new therapies.

Conclusion

Oxana Guerassimenko continues to pave the way for innovation in Alzheimer’s treatment through her extensive research and patent contributions. Her dedication to exploring new therapeutic approaches positions her as a leading inventor in the biomedical field.